Agile Thrpe Stock Fundamentals
| AGRXDelisted Stock | USD 2.94 0.08 2.65% |
Agile Thrpe fundamentals help investors to digest information that contributes to Agile Thrpe's financial success or failures. It also enables traders to predict the movement of Agile Stock. The fundamental analysis module provides a way to measure Agile Thrpe's intrinsic value by examining its available economic and financial indicators, including the cash flow records, the balance sheet account changes, the income statement patterns, and various microeconomic indicators and financial ratios related to Agile Thrpe stock.
Agile |
Agile Thrpe Company Current Valuation Analysis
Agile Thrpe's Enterprise Value is a firm valuation proxy that approximates the current market value of a company. It is typically used to determine the takeover or merger price of a firm. Unlike Market Cap, this measure takes into account the entire liquid asset, outstanding debt, and exotic equity instruments that the company has on its balance sheet. When a takeover occurs, the parent company will have to assume the target company's liabilities but will take possession of all cash and cash equivalents.
Current Agile Thrpe Current Valuation | 633.86 K |
Most of Agile Thrpe's fundamental indicators, such as Current Valuation, are part of a valuation analysis module that helps investors searching for stocks that are currently trading at higher or lower prices than their real value. If the real value is higher than the market price, Agile Thrpe is considered to be undervalued, and we provide a buy recommendation. Otherwise, we render a sell signal.
Enterprise Value can be a useful tool to compare companies with different capital structures. Long term liability and current cash or cash equivalents can have a huge impact on market valuation of a given company.
CompetitionIn accordance with the recently published financial statements, Agile Thrpe has a Current Valuation of 633.86 K. This is 100.0% lower than that of the Pharmaceuticals sector and significantly higher than that of the Health Care industry. The current valuation for all United States stocks is 100.0% higher than that of the company.
Agile Thrpe Fundamental Drivers Relationships
Comparative valuation techniques use various fundamental indicators to help in determining Agile Thrpe's current stock value. Our valuation model uses many indicators to compare Agile Thrpe value to that of its competitors to determine the firm's financial worth. You can analyze the relationship between different fundamental ratios across Agile Thrpe competition to find correlations between indicators driving Agile Thrpe's intrinsic value. More Info.Agile Thrpe is rated below average in return on equity category among its peers. It is rated below average in return on asset category among its peers . The reason why the comparable model can be used in almost all circumstances is due to the vast number of multiples that can be utilized, such as the price-to-earnings (P/E), price-to-book (P/B), price-to-sales (P/S), price-to-cash flow (P/CF), and many others. The P/E ratio is the most commonly used of these ratios because it focuses on the Agile Thrpe's earnings, one of the primary drivers of an investment's value.Agile Current Valuation Peer Comparison
Stock peer comparison is one of the most widely used and accepted methods of equity analyses. It analyses Agile Thrpe's direct or indirect competition against its Current Valuation to detect undervalued stocks with similar characteristics or determine the stocks which would be a good addition to a portfolio. Peer analysis of Agile Thrpe could also be used in its relative valuation, which is a method of valuing Agile Thrpe by comparing valuation metrics of similar companies.Agile Thrpe is currently under evaluation in current valuation category among its peers.
Agile Fundamentals
| Return On Equity | -13.64 | |||
| Return On Asset | -0.97 | |||
| Profit Margin | (0.70) % | |||
| Operating Margin | (0.60) % | |||
| Current Valuation | 633.86 K | |||
| Shares Outstanding | 2.96 M | |||
| Shares Owned By Insiders | 1.13 % | |||
| Shares Owned By Institutions | 10.13 % | |||
| Number Of Shares Shorted | 222.1 K | |||
| Price To Earning | (4.74) X | |||
| Price To Book | 1.78 X | |||
| Price To Sales | 0.06 X | |||
| Revenue | 19.98 M | |||
| Gross Profit | (6.62 M) | |||
| EBITDA | (22.33 M) | |||
| Net Income | (13.93 M) | |||
| Cash And Equivalents | 13.03 M | |||
| Cash Per Share | 0.33 X | |||
| Total Debt | 2.21 M | |||
| Debt To Equity | 3.95 % | |||
| Current Ratio | 0.64 X | |||
| Book Value Per Share | (5.45) X | |||
| Cash Flow From Operations | (11.31 M) | |||
| Short Ratio | 0.28 X | |||
| Earnings Per Share | 7.31 X | |||
| Target Price | 5.0 | |||
| Number Of Employees | 22 | |||
| Beta | 1.5 | |||
| Market Capitalization | 1.17 M | |||
| Total Asset | 14.24 M | |||
| Retained Earnings | (408.7 M) | |||
| Working Capital | (2.03 M) | |||
| Current Asset | 54.76 M | |||
| Current Liabilities | 8.37 M | |||
| Z Score | -43.8 | |||
| Net Asset | 14.24 M |
About Agile Thrpe Fundamental Analysis
The Macroaxis Fundamental Analysis modules help investors analyze Agile Thrpe's financials across various querterly and yearly statements, indicators and fundamental ratios. We help investors to determine the real value of Agile Thrpe using virtually all public information available. We use both quantitative as well as qualitative analysis to arrive at the intrinsic value of Agile Thrpe based on its fundamental data. In general, a quantitative approach, as applied to this company, focuses on analyzing financial statements comparatively, whereas a qaualitative method uses data that is important to a company's growth but cannot be measured and presented in a numerical way.
Please read more on our fundamental analysis page.Agile Therapeutics, Inc., a womens healthcare company, researches, develops, and commercializes prescription contraceptive products for women in the United States. Agile Therapeutics, Inc. was incorporated in 1997 and is headquartered in Princeton, New Jersey. Agile Therapeutics operates under Drug ManufacturersSpecialty Generic classification in the United States and is traded on NASDAQ Exchange. It employs 30 people.
Also Currently Popular
Analyzing currently trending equities could be an opportunity to develop a better portfolio based on different market momentums that they can trigger. Utilizing the top trending stocks is also useful when creating a market-neutral strategy or pair trading technique involving a short or a long position in a currently trending equity.Check out Trending Equities to better understand how to build diversified portfolios. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in metropolitan statistical area. You can also try the ETFs module to find actively traded Exchange Traded Funds (ETF) from around the world.
Other Consideration for investing in Agile Stock
If you are still planning to invest in Agile Thrpe check if it may still be traded through OTC markets such as Pink Sheets or OTC Bulletin Board. You may also purchase it directly from the company, but this is not always possible and may require contacting the company directly. Please note that delisted stocks are often considered to be more risky investments, as they are no longer subject to the same regulatory and reporting requirements as listed stocks. Therefore, it is essential to carefully research the Agile Thrpe's history and understand the potential risks before investing.
| Price Ceiling Movement Calculate and plot Price Ceiling Movement for different equity instruments | |
| Theme Ratings Determine theme ratings based on digital equity recommendations. Macroaxis theme ratings are based on combination of fundamental analysis and risk-adjusted market performance | |
| Commodity Directory Find actively traded commodities issued by global exchanges | |
| Options Analysis Analyze and evaluate options and option chains as a potential hedge for your portfolios | |
| Performance Analysis Check effects of mean-variance optimization against your current asset allocation | |
| CEOs Directory Screen CEOs from public companies around the world | |
| Volatility Analysis Get historical volatility and risk analysis based on latest market data | |
| Piotroski F Score Get Piotroski F Score based on the binary analysis strategy of nine different fundamentals | |
| Portfolio Backtesting Avoid under-diversification and over-optimization by backtesting your portfolios |